A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancer.
Journal Information
Full Title: Surg Today
Abbreviation: Surg Today
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: General Surgery
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestWe have no competing interests to declare. Ethics approvalThis study was approved by the Ethics Committee of Kagoshima University (approval number: 200043). Consent to participateWe conducted a retrospective study and used the “opt-out” method as a way to obtain informed consent from patients. Consent for publicationNot applicable. Conflict of interest We have no competing interests to declare."
"Funding This work was supported in part by grants-in-aid (no. 19K09200) for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025